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Carvacrol, a monoterpenic phenol present in essential oils of the Labiatae family, has been used 
through the ages as a source of flavor in food and for medicinal purposes. Borneol is a monoterpene 
found in several species of Artemisia and Dipterocarpaceae, used for anxiety, pain and anesthesia in 
traditional Chinese. Citral, a mixture of two geometrical isomers (neral and geranial), is one of the most 
important compounds in some citrus oils and has central nervous system (CNS) properties. The 
anticonvulsant effect of carvacrol (CARV), (−)-borneol (BOR) and citral (CIT) was investigated in two 
animal models of epilepsy. Mice were pretreated with CARV, BOR or CIT (50, 100, and 200 mg/kg, i.p.) 
30 min before pentylenetetrazole (PTZ) or maximal electroshock (MES) tests, the two most important 
animal epilepsy tests. The latency for development of convulsions and protection percentage was 
recorded. In order to investigate the involvement of GABAergic system, flumazenil was utilized. These 
monoterpenes, CARV in a higher, but not in a lower dose (p < 0.001), BOR and CIT in all doses (p < 0.05 
or p < 0.001), were capable of promoting an increase of latency for the development of convulsions 
induced by PTZ. Additionally, these compounds were efficient in preventing the tonic convulsions (p < 
0.05) induced by MES. However, the GABAergic neurotransmitter system might be involved, at least in 
BOR effects. Henceforth, our results suggest that CARV, BOR and CIT possess anticonvulsant activity 
effect against PTZ-induced convulsions and MES. 
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INTRODUCTION 
 
Epilepsy is the most frequent neurologic infection charac-
terized by excessive temporary neuronal discharge. The 
overall prevalence of the disease is 1.0% of the popu-
lation and up to 50 million people worldwide  (McCagh  et 
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al., 2009). Despite the development of several new anti-
convulsants, the treatment of epilepsy still remains 
inadequate. About one third of patients do not respond 
well to currently available treatment, even if multiple 
drugs with complementary activities are used (WHO, 
2001). Furthermore, more than 50% of epilepsy patients 
experience undesired side effects of drug treatment and 
even life-threatening conditions (Löscher and Schmidt, 
2006). However, numerous therapeutic approaches are 
being   used   to   better   control  the  widespread  clinical  
  
 
 
 
problem of convulsive attacks that affect a significant 
proportion of the human population (Araújo et al., 2003). 
One approach is to discover new anticonvulsive drugs 
from natural sources with enhanced efficacy and minimal 
side effects (Nsour et al., 2000; Schachter, 2009). 
In this regard, essential oils are volatile compounds 
produced by aromatic plants that have been found to 
exhibit a variety of biological properties, such as anal-
gesic (Melo et al., 2010), cardiovascular (Menezes et al., 
2010) and anticonvulsant (De Sousa et al., 2006; De 
Sousa et al.,  2007a; De Sousa et al., 2007b; Silva et al., 
2009). Monoterpenes are the primary components of 
these essential oils and the effects of many medicinal 
herbs have been attributed to them (Carlini, 2003; 
Quintans-Júnior et al., 2008a). 
Carvacrol (CARV), the predominant monoterpenic phe-
nol present in many essential oils of the Labiatae family 
including Origanum, Satureja, Thymbra, Thymus and 
Corydothymus species, has been used through the ages 
as a source of flavor in food  and for medicinal purposes 
(Kirimer et al., 1995). Some biological effects, such as 
analgesic (Aydin et al., 1996) and antioxidant (Aeschbach 
et al., 1994) activities have also been reported.  
Borneol (BOR), a bicyclic monoterpenoid alcohol, pre-
sent in the essential oils of numerous medicinal plants of 
the Dipterocarpaceae (e.g. Dipterocarpus turbinatus 
tree), Lamiaceae (e.g. Rosmarinus officinalis or Salvia 
officinalis), Valerianaceae (e.g. Valeriana officinalis) or 
Asteraceae (e.g. Matricaria chamomilla) families, has 
been used as a therapeutic agent in China for over 1500 
years (Hattori, 2000; Xiao-fei et al., 2008; Horváthová et 
al., 2009). According to the pharmacopoeia of People's 
Republic of China, BOR is an ingredient in about 63 
herbal products (SPC, 2005). In folk remedies, BOR is 
used also for several other purposes, such as treatment 
of abdominal pain, particularly stomachache, for appli-
cation on injuries, burns, to relieve rheumatic pains, 
haemorrhoids, skin diseases, ulcerations of the mouth, 
ear, eye or nose and in aromatherapy (Wang et al., 2006; 
Horváthová et al., 2009). Likewise, citral (CIT) is one of 
the most important flavor compounds in some citrus oils. 
Citral consists of a mixture of two geometrical isomers, 
neral and geranial, and is highly susceptible to acid-
promoted and oxidative degradation (Kimura et al., 
1983). Gurgel do Vale et al. (2002) demonstrated central 
nervous system (CNS) properties of citral, limonene and 
myrcene in rodents, such as hypnotic and anxiolytic. 
However, little is known about the CNS effects of CARV, 
(−)-BOR and citral. 
Since several monoterpenes demonstrate CNS activity, 
such as anticonvulsant and anxiolytic, and since there is 
no literature reports of studies about the anticonvulsant 
activity of CARV, BOR and CIT, we decided to further 
explore these effects using the two most important animal 
models of epilepsy (Smith et al, 2007): pentylenetetrazole 
(PTZ)-induced convulsion and maximal electroshock test 
(MES). 
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MATERIALS AND METHODS 
 
Drugs 
 
The drugs used were PTZ, phenytoin (PHE), polyoxyethylene-
sorbitan monolated (Tween 80), purchased from Sigma (St Louis, 
MO., USA); Diazepam (DZP) and flumazenil (FLU), from Cristália 
(Brazil). Carvacrol (CARV, with 99.9% purity), BOR with 95.0% 
purity and CIT with 96.0% purity, (mixture of cis and trans) were 
purchased from Sigma (St Louis, MO., USA). Agents were admini-
stered intraperitoneally (i.p.) at a dose volume of 0.1 ml/10 g. 
 
 
Experimental animals and research protocol approval 
 
Male Swiss mice (30 - 35 g), 2 - 3 months of age, were used 
throughout this study. They were kept in the departmental animal 
house inside a well cross ventilated room at 25 ± 2°C on a 12 h 
light/dark cycle (lights on 06:00 - 18:00 h) with free access to food 
(purina) and water. They were used in groups of 10 animals each. 
All experiments were carried out between 09:00 am and 04:00 pm 
in a quiet room. Experimental protocols and procedures were 
approved by the Animal Care and Use Committee (CEPA/UFS # 
26/09) at the Federal University of Sergipe, Brazil.  
 
 
PTZ convulsion test 
 
The inhibitory effect of CARV, BOR and CIT were tested on PTZ-
induced convulsion. Mice were divided into groups (n = 10, each), 
the first group worked as control and received vehicle (2 drops of 
tween 80 0.2% in distilled water, the solvent for monoterpenes), 
whereas the second group was treated with diazepam (DZP, 2 
mg/kg, i.p.). A pilot study showed that the vehicle did not possess 
anticonvulsant effect (data not shown). The remaining groups 
received an injection of CARV, BOR or CIT (50, 100, or 200 mg/kg, 
i.p.). After 30 min of drug administration, the mice were treated with 
PTZ (i.p.) at a dose of 60 mg/kg to induce clonic convulsions (Smith 
et al., 2007). The latency and percentage of clonic convulsions 
inhibition were registered. The incidence of deaths was registered 
during 48 h after the injection of PTZ.  
 
 
Effects of flumazenil on PTZ-induced convulsion  
 
The effects of selective γ-amino-butyric acid-benzodiazepine 
(GABAA-BZD) receptor antagonist, flumazenil (File and Pellow, 
1986), on the anticonvulsant activity of CARV, BOR and CIT were 
investigated. In the experimental groups; mice were given 
flumazenil (FLU) (10 mg/kg, i.p.) 20 min before the administration of 
monoterpenes (CARV, BOR or CIT, 200 mg/kg, i.p.) (50 min before 
the injection of PTZ). In the standard group, the animals received 
FLU 20 min before the administration of diazepam (DZP, 2 mg/kg, 
i.p.) (50 min before the injection of PTZ). The anticonvulsant activity 
of CARV, BOR, CIT or DZP in mice pretreated with FLU was 
assessed. 
 
 
Maximal electroshock test 
 
MES produces reproducible tonic convulsions characterized by 
tonic hindlimb extension (THE) (Oliveira et al., 2001). In this 
experiment, electroconvulsive shock (130 V, 150 pulses/s, 0.5 s) 
was delivered through auricular electrodes (ECT UNIT 7801- Ugo 
Basile) to induce THE. Mice were divided into groups (n = 10, per 
group), the first group was used as control and received vehicle, 
while the second group was treated with PHE (25 mg/kg, i.p.). The 
other groups received an  injection  of  monoterpenes,  in  a  similar  
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Figure 1. Protective effect of carvacrol (CARV, 50, 100 or 200 mg/kg, i.p.) against convulsion 
produced after PTZ (60 mg/kg, i.p.) injection in mice. The effects of CARV on latency (A) and 
percentage (%) protection (B). Results are expressed as mean ± SEM, n = 10 in each group. *, 
**Significant at p < 0.05 and 0.001, respectively, as compared to control (vehicle), one way 
ANOVA followed by Dunnet’s test. #, ##significant at p < 0.01 and 0.001, respectively, compared 
with control (no protection), Fisher`s exact test. 
 
 
 
way, before the experiment. After 30 min, all groups received elec-
troconvulsive shock. The animals that did not exhibit THE were 
considered protected during the time of tonic convulsion (Tortoriello 
and Ortega, 1993). 
 
 
Statistical analysis 
 
The data obtained were evaluated by one-way analysis of variance 
(ANOVA) followed by Dunnett`s t test. The incidence (%) of clonic 
or tonic-clonic convulsions, as well as the mortality, were evaluated 
by Fisher`s exact test. Differences were considered to be statis-
tically significant when p < 0.05. 
 
 
RESULTS 
 
The effects of CARV, BOR or CIT on PTZ-induced con-
vulsions are shown in Figure 1, 2 and 3, respectively. 
Single dose i.p. administration of PTZ (60 mg/kg, i.p.) 
caused clonic convulsions as well as lethality in mice.  
As shown in Figure 1 (A and B), pretreatment with the 
CARV at higher dose (200 mg/kg, i.p.) significantly 
increased time onset of clonic convulsions (latency) (p < 
0.001) and protected animals from PTZ-induced convul-
sion (p < 0.01) in mice as compared to control group. 
However, mortality did not alter through CARV admini-
stration (data not shown). The pretreatment with DZP (2 
mg/kg, i.p.) significantly prolonged the latencies and was 
effective in preventing clonic seizures induced by PTZ in 
90% of the animals (p < 0.001). 
In the control group, PTZ consistently induced clonic 
seizures in 100% of mice. Pretreatment with the BOR at 
all doses significantly reduced (p < 0.05 or p < 0.001) in a 
dose-dependent manner; the incidence of clonic PTZ 
convulsion, significantly  increased  the  latency  of  clonic  
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Figure 2. Protective effect of (−)-borneol (BOR, 50, 100 or 200 mg/kg, i.p.) against convulsion 
produced after PTZ (60 mg/kg, i.p.) injection in mice. The effects of BOR on latency (A) and 
percentage (%) protection (B). Results are expressed as mean ± SEM, n = 10 in each group. *, 
**Significant at p < 0.05 and 0.001, respectively, as compared to control (vehicle), one way ANOVA 
followed by Dunnet’s test. #, ##significant at p < 0.01 and 0.001, respectively,  compared with control 
(no protection), Fisher`s exact test. 
 
 
 
convulsion at the tested doses. DZP (2 mg/kg) blocked 
the clonic convulsions and mortality (data not shown) 
induced by PTZ in mice. Nevertheless, the administration 
of FLU (10 mg/kg, i.p.) antagonized the effect of BOR or 
DZP in the prolongation of convulsion latency (Figure 2). 
Mice pretreated with CIT, at all doses, showed signifi-
cant (p < 0.05 or p < 0.001) increase in time onset of 
clonic convulsions (latency) which significantly (p < 0.05) 
protected animals from PTZ-induced convulsion in mice. 
These results were not antagonized by FLU, as shown in 
Figure 3 (A and B). Additionally, mortality was signifi-
cantly reduced (p < 0.05) by CIT (100 and 200 mg/kg) 
administration (data not shown). 
As shown in Table 1, CARV (200 mg/kg), BOR (100 
and 200 mg/kg) and CIT (100 and 200 mg/kg) were 
effective in preventing tonic convulsions induced by MES. 
However, the highest dose of CIT (40% of protection) 
was less effective as compared to 100 mg/kg (60% of 
protection). Standard group (PHE, 25 mg/kg) completely 
protected the animals from tonic convulsion (p < 0.001).  
 
 
DISCUSSION  
 
The main goal of this study is to evaluate the effects of 
CARV, BOR or CIT on the anticonvulsant activity using 
two animal tests of convulsion: PTZ-induced convulsions 
and MES. 
The new drugs with antiepileptic activity (AEDs) are 
identified and developed as a result of their ability to 
block induced acute convulsions in animal models of 
epilepsy. Amongst the several models used in the 
discovery of new drugs, MES, the test of PTZ and the 
kindling in rats are used in programs for the  discovery  of  
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Figure 3. Protective effect of citral (CIT, 50, 100 or 200 mg/kg, i.p.) against convulsion produced 
after PTZ (60 mg/kg, i.p.) injection in mice. The effects of CIT on latency (A) and percentage (%) 
protection (B). Results are expressed as mean ± SEM, n = 10 in each group. *, **Significant at p 
< 0.05 and 0.001, respectively,  as compared to control (vehicle), one way ANOVA followed by 
Dunnet’s test. #, ##significant at p < 0.01 and 0.001, respectively, compared with control (no 
protection), Fisher`s exact test. 
 
 
 
Table 1. Effects of CARV, BOR or CIT on maximal electroshock test in mice. 
 
Treatment Dose (mg/kg) % Inhibition of convulsion Time spent of convulsioning (s) 
Vehicle - 0 16.0 ± 0.3 
PHE 25 100## 0.0 ± 0.0** 
CARV 50 0 15.8 ± 1.2 
CARV 100 20 19.7 ± 4.2 
CARV 200 40# 9.0 ± 3.8* 
BOR 50 0 17.3 ± 1.9 
BOR 100 40# 8.5 ± 1.6* 
BOR 200 60## 7.1 ± 2.3** 
CIT 50 0 15.0 ± 0.9 
CIT 100 60## 8.0 ± 3.6* 
CIT 200 40# 7.0 ± 1.1* 
 
*, **Significant at p < 0.05 and 0.001, respectively, as compared to vehicle (control group), one way ANOVA 
followed by Dunnet’s test. #, ##significant at p < 0.01 and 0.001, respectively, compared with control (no 
protection), Fisher`s exact test. 
  
 
 
 
new antiepileptic drugs (White et al., 1998; Löscher and 
Schmidt, 2006; Smith et al., 2007). PTZ is considered as 
an experimental model for the “generalized absence con-
vulsions” (Oliveira et al., 2001). PTZ has been reported to 
produce convulsions by inhibiting GABA neurotran-
smission (Löscher and Schmidt, 2006). GABA is the main 
inhibitory neurotransmitter substance in the brain, and is 
widely implicated in epilepsy. Enhancement of GABAergic 
neurotransmission has been shown to inhibit or attenuate 
convulsion, while inhibition of GABAergic neurotrans-
mission or activity is known to promote and facilitate 
convulsion (Haruna, 2000; Smith et al., 2007). BOR and 
CIT were more effective than CARV for all doses and 
increased time onset of clonic convulsions, while CARV 
was effective only at the highest dose. Nevertheless, 
antagonism of PTZ-induced convulsion suggests that the 
CARV, BOR and CIT might have effects on GABAergic 
neurotransmission. 
Generally, compounds that possess anticonvulsant 
activity in the epilepsy of the lesser types are effective in 
inhibiting the convulsions in the model of the PTZ (Vida, 
1995). Therefore, the capacity of these monoterpenes 
(BOR and CIT with better effects than CARV) to promote 
protection against PTZ-induced convulsions suggests the 
profile of an anticonvulsant drug that could be useful in 
these types of crises. In order to determine the role of 
GABAA-BZD receptors participation in the monoterpenes 
(CARV, BOR or CIT) induced anticonvulsant effects, 
FLU, a specific antagonist of the BZD site in the GABAA-
BZD receptor complex, was used (File and Pellow, 1986). 
However, the presence of FLU was not capable of 
reverting the anticonvulsant effect of monoterpenes 
(CARV and CIT), suggesting that the mechanism of 
action does not involve the direct activation of the BZD site 
of the GABAA-BZD receptor. In contrast, when the effect of 
BOR was evaluated using FLU, it produced significant 
antagonism. Interestingly, this result was different from 
that found by Granger et al. (2005) that showed a positive 
modulation on the channel which is unrelated to the 
GABAA-BZD receptor. 
An increasing number of natural agents have been 
found to modulate ionotropic GABA receptors indepen-
dently of benzodiazepine sites, including the monoter-
penes (+)- and (−)-borneol (Granger et al., 2005), thymol 
(Johnston, 2005), citronellol (De Sousa et al., 2006) and 
α,β-epoxy-carvone (Almeida et al., 2008). Granger et al. 
(2005) demonstrate that (+)- and (-)-borneol are highly 
efficacious as positive modulators of the effects of low 
GABA concentrations at human recombinant α1β2γ2L 
GABAA receptors. 
MES test is the most frequently used animal model for 
the identification of anticonvulsant activity of drugs for the 
“grand mal” (Oliveira et al., 2001; Smith et al., 2007). All the 
currently available antiepileptic activity, which are clinically 
effective in the treatment of generalized tonic-clonic con-
vulsions, PHE, phenobarbital, lamotrigine and carbama-
zepine, are effective in the MES test (Löscher, 1998). Our 
results suggest that  monotepenes  (CARV,  BOR or CIT)  
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may prove to be important chemical leads for future 
antiepileptic activity. 
Some essential oils of plants have been used in folk 
medicine as an antiepileptic remedy (Quintans-Júnior et 
al., 2008b). Pharmacological studies have demonstrated 
the anticonvulsant properties of these essential oils in 
animal models and their biological effects have been 
attributed to the monoterpenes (Nsour et al., 2000; 
Schachter, 2009). The protective effects of the essential 
oils can occur through different mechanisms due to the 
diversity of chemical constituents. Several terpenes of 
essential oils present sedative and hypnotic effects (De 
Sousa et al., 2007c). Recently, our group demonstrated 
that citronellal, α-terpineol  and citronellol and other 
monoterpenes, possess significant CNS depressant 
activity, such as sedative, hypnotic, anticonvulsant and 
central analgesic properties (De Sousa et al., 2006; De 
Sousa et al., 2007a; Melo et al., 2010; Quintans-Júnior et 
al., 2010). These effects may be associated with GAB 
Aergic system and decreased peripheral nerve excitability. 
 
 
Conclusion 
 
Summarizing our data, the results suggest a possible 
anticonvulsant effect of CARV, BOR and CIT. The 
precise mechanisms of possible behavioral effects of 
these compounds are not yet fully understood. However, 
regarding BOR, these effects are probably observed 
through the modulation of GABAergic system through 
enhancement of GABAA-BZD receptor. Nevertheless, 
more studies will be required for the elucidation of the 
relationship between this effect and the neuronal mec-
hanisms. 
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